The startup develops a neurovascular medical device that integrates with a mechanically detachable embolic coil for endovascular treatment of cerebrovascular diseases. This technology enhances procedural safety and efficiency for neuroradiologists, neurosurgeons, and vascular surgeons, leading to improved clinical outcomes.
Funding
$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Endovascular treatment of cerebrovascular diseases relies on the precise and safe placement of embolic coils. Current methods may present challenges in achieving optimal coil deployment, potentially leading to procedural complications and suboptimal clinical outcomes.
Solution
Spartan Micro develops the Spartan eCoil™ System, a neurovascular medical device designed to enhance the safety and efficiency of endovascular procedures. The system integrates a mechanically detachable embolic coil, allowing for controlled and precise deployment during the treatment of cerebrovascular diseases and abnormalities. By providing specialist physicians with improved tools, Spartan Micro aims to facilitate faster and safer procedures, ultimately driving improved clinical outcomes for patients. The company focuses on innovation in the neurovascular market, addressing both common and uncommon cerebrovascular conditions.
Target Audience
The primary users are interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists, and vascular surgeons specializing in the endovascular treatment of cerebrovascular diseases.
Features
- Mechanically detachable embolic coil for controlled deployment
- Designed for endovascular treatment of cerebrovascular diseases
- Aims to improve procedural safety and efficiency
- Targets faster and safer procedures